Vitamin A and tumor immunity
- 1 January 1985
- journal article
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 41 (1) , 92-93
- https://doi.org/10.1007/bf02005892
Abstract
Intraperitoneal administration of vitamin A into the BALB/c mice inoculated with a syngeneic fibrosarcoma, Meth A, caused a remarkable augmentation of tumor rejection. A cell-depletion technique revealed that the primary effector cells responsible for the augmented rejection were Thy-1 positive, Lyt-1 negative, Lyt-2 positive lymphocytes, suggesting the involvement of cytotoxic lymphocytes.Keywords
This publication has 12 references indexed in Scilit:
- T-cell-mediated enhancement of host-versus-graft reactivity in mice fed a diet enriched in vitamin A acetateNature, 1983
- Evidence for cytostatic T cell activity in the effector mechanism against syngeneic TMT mammary tumor cells in mice.The Journal of Immunology, 1983
- Combined Treatments With Vitamin A and 5-Fluorouracil and the Growth of Allotransplantable and Syngeneic Tumors in Mice2, 3JNCI Journal of the National Cancer Institute, 1982
- Thy and Ly markers on lymphocytes initiating tumor rejectionCellular Immunology, 1981
- Cell-mediated cytotoxicity against syngeneic tumorsCellular Immunology, 1981
- Effects of vitamin A and its analogs (retinoids) on normal and neoplastic cellsBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1980
- Augmentation of specific tumor immunity against a syngeneic SV40-induced sarcoma in mice by retinoic acidCellular Immunology, 1979
- Effects of retinoic acid on the immune system: Stimulation of T killer cell inductionEuropean Journal of Immunology, 1978
- Inhibition of the Growth and Development of a Transplantable Murine Melanoma by Vitamin AScience, 1975
- Adjuvanticity of Vitamin ANature, 1968